Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202643 · ClinicalTrials.gov registry record · Phase 1
Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF
A Phase 1 study, sponsored by Center for Human Reproduction.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01202643 is a Phase 1 study that was terminated before completion, run by Center for Human Reproduction. The registered enrollment target is 12 participants.
The verdict
NCT01202643, a Phase 1 study, was terminated before completion, sponsored by Center for Human Reproduction.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effect of G-CSF on endometrial thickness in women who have failed reaching minimal endometrial thickness by standard treatments, to assess how many reach embryo transfer and what implantation and pregnancy rates are in comparison to control patients. The study will be conducted in women undergoing transfer of previously cryopreserved embryos or undergoing transfer of embryos from donor eggs.
Interventions
- DRUG G-CSF
- DRUG Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01202643
The ClinicalTrials.gov registry entry for NCT01202643 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which G-CSF is the first listed.
NCT01202643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01202643 about?
NCT01202643 is a clinical study titled "Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF". The purpose of this study is to investigate the effect of G-CSF on endometrial thickness in women who have failed reaching minimal endometrial thickness by standard treatments, to assess how many reach embryo transfer and what implantation and pregnancy rates are in comparison to control patients. T...
What is the current status of trial NCT01202643?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2010-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01202643?
The interventions under investigation include: G-CSF (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT01202643?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.